Research projects

Groundbreaking and Ambitious

Innovative and ambitious projects

Brightlands is running an impressive number of innovative and ambitious projects, all of which attest to first-rate research and result in outstanding teaching and superior health care. Brightlands is the place to be to conduct groundbreaking studies and take important steps forward in health, nutrition, and materials.


The Maastricht Study

The Maastricht Study is a unique look into the prevalence, causes, and treatment of type 2 diabetes, cardiovascular disease, and other chronic diseases in the Maastricht Aachen region. Brightlands assesses Study participants at the start and then again five years later. Its aim is to understand why one person develops type 2 diabetes and another does not. Ultimately, the Maastricht Study will make a significant contribution to combating a wide range of diseases.

For more information visit the website of The Maastricht Study.


Scannexus is establishing a European Center of Excellence for ultra-high magnetic field MRI and neuroscience at Brightlands Maastricht Health Campus. Using three fMRI scanners with ultra-high magnetic fields of 3.0, 7.0 and 9.4 Tesla, the integrated platform provides scientists and companies with the means to find the key to common diseases such as Alzheimer's, Parkinson's, epilepsy, and MS, and gain more insight into the evolution of human behavior.

Scannexus' mission aims to bridge the gap between research and industry, and establish spin-offs is essential to that process. Scannexus therefore also provides value creation for knowledge and stimulates entrepreneurship in mental health care and cognitive neuroscience.

For more information visit the website of Scannexus.

Maastricht Cardiovascular Center of Excellence

The MCCE chose Brightlands so it could benefit from its leading position in cardiovascular research at the Cardiovascular Research Institute Maastricht (CARIM) and clinical care at the Cardiovascular Center (Hart en Vaat Centrum). The MCCE combines its results derived from first-class research and excellent clinical care. It then offers a wide range of basic treatments and supports initiatives defined within the CARIM research school and the Cardiovascular Center. It also collaborates intensively with world leading businesses in the cardiovascular market.